Explore
Validate
Learn10986-1-AP
antibody from Proteintech Group
Targeting: NDUFA13
B16.6, CDA016, CGI-39, GRIM-19, GRIM19
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10986-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10986-1-AP, RRID:AB_2150609
- Product name
- GRIM19 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated GRIM19 antibody (Cat. #10986-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation.
Folate regulates RNA m(5)C modification and translation in neural stem cells.
PDGF signaling inhibits mitophagy in glioblastoma stem cells through N(6)-methyladenosine.
GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis.
GRIM-19 deficiency promotes clear cell renal cell carcinoma progression and is associated with high TNM stage and Fuhrman grade.
Clinical and molecular findings in a family expressing a novel heterozygous variant of the G elongation factor mitochondrial 1 gene.
Nonviral Delivery of GRIM-19 Gene Inhibits Tumor Growth with Reduced Local and Systemic Complications.
Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Atrazine promotes RM1 prostate cancer cell proliferation by activating STAT3 signaling.
Wang M, Wang J, Wang L, Feng X, Qian Y, Ye C, Wang C
Phytotherapy research : PTR 2024 Feb;38(2):839-855
Phytotherapy research : PTR 2024 Feb;38(2):839-855
Folate regulates RNA m(5)C modification and translation in neural stem cells.
Xu X, Johnson Z, Wang A, Padget RL, Smyth JW, Xie H
BMC biology 2022 Nov 23;20(1):261
BMC biology 2022 Nov 23;20(1):261
PDGF signaling inhibits mitophagy in glioblastoma stem cells through N(6)-methyladenosine.
Lv D, Gimple RC, Zhong C, Wu Q, Yang K, Prager BC, Godugu B, Qiu Z, Zhao L, Zhang G, Dixit D, Lee D, Shen JZ, Li X, Xie Q, Wang X, Agnihotri S, Rich JN
Developmental cell 2022 Jun 20;57(12):1466-1481.e6
Developmental cell 2022 Jun 20;57(12):1466-1481.e6
GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis.
Wang D, Wei X, Chen X, Wang Q, Zhang J, Kalvakolanu DV, Guo B, Zhang L
Experimental cell research 2021 Oct 1;407(1):112799
Experimental cell research 2021 Oct 1;407(1):112799
GRIM-19 deficiency promotes clear cell renal cell carcinoma progression and is associated with high TNM stage and Fuhrman grade.
Yan N, Feng X, Jiang S, Sun W, Sun MZ, Liu S
Oncology letters 2020 Jun;19(6):4115-4121
Oncology letters 2020 Jun;19(6):4115-4121
Clinical and molecular findings in a family expressing a novel heterozygous variant of the G elongation factor mitochondrial 1 gene.
Su C, Wang F
Experimental and therapeutic medicine 2020 Dec;20(6):173
Experimental and therapeutic medicine 2020 Dec;20(6):173
Nonviral Delivery of GRIM-19 Gene Inhibits Tumor Growth with Reduced Local and Systemic Complications.
Xu Y, Wang X, Guo B, Wang D, Kalvakolanu DV, Chen X, Tang J, Zhang L, Yang Q
Human gene therapy 2019 Nov;30(11):1419-1430
Human gene therapy 2019 Nov;30(11):1419-1430
Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F, Yan CY, Zhou S, Hui PY, Du YH, Zheng L, Yu J, Hu XJ, Zhang ZG
Cancer chemotherapy and pharmacology 2018 Oct;82(4):593-605
Cancer chemotherapy and pharmacology 2018 Oct;82(4):593-605
Atrazine promotes RM1 prostate cancer cell proliferation by activating STAT3 signaling.
Hu K, Tian Y, Du Y, Huang L, Chen J, Li N, Liu W, Liang Z, Zhao L
International journal of oncology 2016 May;48(5):2166-74
International journal of oncology 2016 May;48(5):2166-74
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human placenta tissue were subjected to SDS PAGE followed by western blot with 10986-1-AP(GRIM19 antibody) at dilution of 1:800
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The GRIM19 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human GRIM19. This antibody recognizes human,mouse,rat antigen. The GRIM19 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
